drugset / Trial / NCT04129983

Treatment of Sudden Deafness With Prednisone+Hyperbaric Oxygen and Prednisone+Somatosensory Stimulation

NCT04129983

Unknown 60 enrolled Dan Su
RandomizedParallel-groupDouble-blindTreatment

Summary

To study the effective treatment of sudden deafness by giving prednisone, hyperbaric oxygen and somatosensory stimulation to sudden deafness patients.

Timeline

Start
2020-06
Primary completion
2020-07
Completion
2020-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisone Other / unclassified 1 mg/kg